Amendment AA6-ASA1-AB69

LRBa0116/1

MED:jld

2017 - 2018 LEGISLATURE

ASSEMBLY AMENDMENT 6, TO ASSEMBLY SUBSTITUTE AMENDMENT 1, TO ASSEMBLY BILL 69

March 7, 2017 - Offered by Representative Riemer.

AB69-ASA1-AA6,1,1 At the locations indicated, amend the substitute amendment as follows:

AB69-ASA1-AA6,1,2 1. Page 3, line 16: after that line insert:

AB69-ASA1-AA6,1,8 “(2m) Physician to report results. The treating physician of an eligible patient who uses an investigational drug, device, or biological product as provided in this section shall, at the conclusion of treatment, provide the federal food and drug administration and the manufacturer with a written summary of the results of the use of the investigational drug, device, or biological product, including any adverse effects.”.

AB69-ASA1-AA6,1,9 (End)